Crystal Structure of Arginase from Plasmodium falciparum and Implications for L-Arginine Depletion in Malarial Infection
Daniel P. Dowling, Monica Ilies, Kellen L. Olszewski, Silvia Portugal, Maria M. Mota, Manuel Llinas, David W. Christianson and Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
The 2.15 angstrom resolution crystal structure of arginase from Plasmodium falciparum, the parasite that causes cerebral malaria, is reported in complex with the boronic acid inhibitor 2(S)-amino-6-boronohexanoic acid (ABEL) (K-d = 11 mu M). This is the first crystal structure of a parasitic arginase. Various protein constructs were explored to identify an optimally active enzyme form for inhibition and structural studies and to probe the structure and function of two polypeptide insertions unique to malarial arginase: a 74-residue low-complexity region contained in loop L2 and an 11-residue segment contained in loop L8. Structural studies indicate that the low-complexity region is largely disordered and is oriented away from the trimer interface; its deletion does not significantly compromise enzyme activity. The loop L8 insertion is located at the trimer interface and makes several intra- and intermolecular interactions important for enzyme function. In addition, we also demonstrate that arg- Plasmodium herghei sporozoites show significantly decreased liver infectivity in vivo. Therefore, inhibition of malarial arginase may serve as a possible candidate for antimalarial therapy against liver-stage infection, and ABH may serve as a lead for the development of inhibitors.
Crystal Structure of Arginase from Plasmodium falciparum and Implications for L-Arginine Depletion in Malarial Infection
Creators
Daniel P. Dowling - University of Pennsylvania
Monica Ilies - University of Pennsylvania
Kellen L. Olszewski - Princeton University
Silvia Portugal - University of Lisbon
Maria M. Mota - University of Lisbon
Manuel Llinas - Center for Disease Dynamics, Economics & Policy
David W. Christianson - University of Pennsylvania
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Publication Details
Biochemistry (Easton), v 49(26), pp 5600-5608
Publisher
American Chemical Society; Washington, DC
Number of pages
9
Grant note
Fundacao para a Ciencia e Tecnologia (FCT, Portugal); Fundacao para a Ciencia e a Tecnologia (FCT)
GM49758; 1DP2OD001315-01 / National Institutes of Health (NIH); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
National Science Foundation; National Science Foundation (NSF)
Howard Hughes Medical Institute
RR-15301 / National Center for Research Resources at the National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Center for Research Resources (NCRR)
DE-AC02-06CH11357 / U.S. Department of Energy, Office of Basic Energy Sciences; United States Department of Energy (DOE)
Burroughs Wellcome Fund
Resource Type
Journal article
Language
English
Academic Unit
Chemistry
Web of Science ID
WOS:000279197300022
Scopus ID
2-s2.0-77954199478
Other Identifier
991020545127204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: